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Introduction
Osteoporosis is a major global public health concern. The
incidence of osteoporosis and its subsequent morbidity is
expected to increase dramatically over the coming decades
in many regions, including Korea. Although it is considered
as a disease of the elderly, there is now universal agree-
ment that osteoporosis has a pediatric origin
1). If individuals
fail to achieve optimal peak bone mass (PBM) and strength
childhood and adolescence, there is a likelihood of develop-
ment osteoporosis later in life
2). Genetic factors play an
important role in the attainment of PBM. Lifestyle factors
such as physical activity and nutrition are also important
3).
Chronic illness itself and various related treatments also
tend to cause impairment of acquisition of bone mass,
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long-term adult bone health and to increase the risk of
fracture
4, 5). Furthermore, increased knowledge and im-
proved care for children with chronic illness has led to
many children living long enough to develop osteoporosis
even in childhood or adolescence
4, 5).
Measurement of bone mineral density (BMD) by dual-
energy X-ray absorptiometry (DXA) is the gold standard
method for non-invasive diagnosis of osteoporosis
6, 7). The
World Health Organization (WHO) reported a classification
of BMD for the diagnosis of osteoporosis based on DXA.
DXA is easy to perform, safe, and clinically acceptable for
children as well as adults. Thus, the use of pediatric DXA
in the clinical and research fields has rapidly increased
8).
This article will discuss the basics of pediatric DXA and
will review normal stages of BMD development of each
region of interest (ROI) and PBM acquisition in Korean
children and adolescents. The indications for pediatric
DXA, clinical practice of pediatric DXA including cautions
on interpretation, and other research applications of DXA
will be described.
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= Abstract =
Peak bone mass is established predominately during childhood and adolescence. It is an important determinant of future
resistance to osteoporosis and fractures to gain bone mass during growth. The issue of low bone density in children and
adolescents has recently attracted much attention and the use of pediatric dual-energy X-ray absorptiometry (DXA) is
increasing. The process of interpretation of pediatric DXA results is different from that of adults
because normal bone mineral density (BMD) of children varies by age, body size, pubertal stage, skeletal maturation, sex,
and ethnicity. Thus, an appropriate normal BMD Z-score reference value with Z-score should be used to detect and manage
low BMD. Z-scores below -2.0 are generally considered a low BMD to pediatrician even though diagnoses of osteoporosis
in children and adolescents are usually only made in the presence of at least one fragility fracture.
This article will review the basic knowledge and practical guidelines on pediatric DXA based on the International Society
for Clinical Densitometry (ISCD) Pediatric Official Positions. Also discussed are the characteristics of normal Korean children
and adolescents with respect to BMD development. The objective of this review is to help pediatricians to understand
when DXA will be useful and how to interpret pediatric DXA reports in the clinical practice for management of children
with the potential to develop osteoporosis in adulthood. (Korean J Pediatr 2010;53:286-293)
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Characteristics of bone mass acquisition
in Korean children and adolescence
The most important aspect of pediatric DXA is to use
an appropriate normative data set because the BMD and
PBM differences are dependent on age, puberty, sex, and
ethnicity
6, 9). A BMD normative data set for Korean children
and adolescents has been recently established and publi-
shed
10, 11). One notable characteristic of Korean children and
adolescents is an earlier onset of BMD acquisition. Other-
wise, the BMD and PBM trends are similar to those of
other ethnicities.
BMD accretion at the lumbar spine in Korean girls has
the highest rate between ages 11 to 13, while boys have
the highest rate between ages 12 to 14, about six months
after peak height velocity. Dutch children have the highest
rate of lumbar spine BMD accretion that occurs one year
later than in Korean children
10). When compared with
Korean adults, the lumbar spine BMD and femur neck BMD
values of Korean girls over 18 yr and Korean boys over
19 yr were the same as the values measured for 20 to
30-yr-old Koreans
12). Therefore, Koreans achieve essen-
tially the same peak BMD in the lumbar spine and femur
neck late in the second decade of life. On average, 90% of
peak bone mass (PBM) is acquired by the age of 19 in
other ethnicities
2, 7).
During puberty, Koreans have an increase in lumbar
spine BMD, which is similar to that of other ethnic groups.
The percentages of BMD acquisition at the lumbar spine in
Koreans between Tanner stage (TS) 1 and TS 5 were
found to be 65% in girls and 66% in boys. Koreans also
tend to have a higher rate of trabecular bone mass (lumbar
spine) acquisition than cortical bone mass acquisition (total
body or femur neck) during puberty. The whole body BMD
increases to 43% in girls and 51% in boys. Korean girls
also have an earlier onset of the BMD plateau than boys,
as observed for other ethnicities. The plateaus of the
lumbar spine BMD and whole body BMD in girls occurred
at ages 15 and 17 respectively. The plateaus of BMDs in
each ROI occurred at age 17 in boys
10).
Bone mineral density and size
in the prediction of fracture risk
Diagnosis of osteoporosis in children remains challen-
ging. In adults, a DXA T-score is defined as the number
of standard deviations (SDs) away from the mean BMD of
a healthy young population. Several epidemiological studies
have confirmed the association between a low BMD T-
score and fracture risk in the elderly population. The frac-
ture risk doubles for every SD decrease in BMD T-score
13). Thus, DXA became the principal tool for diagnosing
adult osteoporosis. In children, the association between low
BMD Z-score and fracture risk is not well established.
However, ISCD adopted DXA in assessing bone mass in
children and growing evidence suggested that low bone
mass might contribute to fracture risk in childhood
14, 15).
Fractures are common and the prime reason for hospit-
alization of children. Forty-two percent of boys and 27%
of girls experience at least one fracture between the age
of 0 to 16
16). Studies in generally healthy children have
found that those who sustain a forearm fracture have a
lower mean bone density than peers without a history of
fracture
17). Recently, a systematic review and meta-analy-
sis of the association between bone density and fractures
in otherwise healthy children concluded that lower total
body and spine BMD can be a predictor of an upper ex-
tremity fracture during puberty
14). The total body less head
(TBLH; the ROI of total body after subtraction of cranium)
bone mineral content (BMC) adjusted bone area is expected
to increase the risk of fracture by about 89% per each SD
decrease. In the same cohort, it was found that fracture
risk from both slight and moderate severe trauma is related –
to changes in TBLH bone size relative to body size
18). A
small increase in the bone diameter will increase bone
strength markedly
19).
Indications for pediatric DXA
Before ordering a DXA analysis, pediatricians should
consider how the information will influence clinical manage-
ment
6, 20). In adults, DXA is performed to predict fracture,
to decide which patients warrant treatment, and to monitor
response to therapy. The rationale for pediatric DXA is
potentially the same in children. The International Society
for Clinical Densitometry (ISCD) has suggested that the
DXA analysis be carried out for any child who is being
treated or considered for treatment of osteoporosis
5). Chil-
dren whose potential fracture risk is likely to exceed that
of normal children should obtain DXA measurements. This
will include children with primary bone diseases (such asJS Lim
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osteogenesis imperfecta and idiopathic juvenile osteoporo-
sis). Children with secondary conditions that affect bone
health should also obtain DXA measurements (Such secon-
dary conditions include immobilization, inflammation, endoc-
rine disturbance, malignancy and treatment, transplantation
recovery apparent osteopenia on radiographs, and systemic
use of long-term steroids)
4, 5, 21). Previous studies have
established that children with chronic disease have lower
BMD than their healthy counterparts
4, 5). Certain children
treated with specific medications, such as corticosteroids,
anticonvulsants, and chemotherapeutic drugs, do not acquire
adequate BMD during growth, and, thus, have an increased
risk of fractures in later life
21, 22). In addition, most children
with chronic disease are subject to risks in skeletal health
as a result of a combination of risk factors including malnu-
trition, malabsorption, vitamin D insufficiency, immobiliza-
tion, deficiency or resistance to sex steroids or growth
hormone, and increased cytokine production
5).
Pediatric DXA testing is not routinely indicated for the
evaluation of all chronic disease. Any additional risk factors
such as disease severity, dose and duration of exposure to
potentially harmful medication, bone pain, a history of frac-
ture after minimal trauma, osteopenia on a plain film, and
recurrent or low-impact fractures history are useful para-
meters for identification of candidates for DXA testing.
Causes of pediatric osteoporosis and commonly indicated
diseases for DXA are listed in Table 1.
Ordering a pediatric DXA analysis
The posterior-anterior (PA) lumbar spine and TBLH are
recommended sites for performing BMC and areal BMD
measurements in both children and adolescents because
the most accurate and reproducible measurements can be
obtained in these areas. The hip (including proximal femur
and total hip) is not a reliable site for measurement in
growing children due to significant variability in skeletal
development, lack of reproducibility and limited normal
reference data
6). However, selection of regions of interest
(ROI) for DXA analysis depends upon clinical concerns and
the options within the clinical setting
8).
For example, sex steroid deficiency typically causes
greater loss in trabecular bone
23). Selecting lumbar spine as
the ROI to be scanned is appropriate as spine is rich in
trabecular bone. On the other hand, growth hormone defi-
ciency causes a predispositions to greater loss of cortical
Table 1. Lists of Diseases Associated with Low Bone Mass or
Fractures in Children and Adolescents
Genetic Defects
Osteogenesis imperfecta
Turner's syndrome (XO)
Klinefelter's syndrome (XXY)
Down's syndrome (21 trisomy)
Ehlers-Danlos syndrome
Marfan syndrome
Phenylketonuria
Glycogen storage disease
Wilson disease
Gaucher disease
Cystic fibrosis
Heredity hemochromatosis
Endocrine disorders
Hypogonadism
Growth hormone deficiency
Cushing's syndrome
Primary hyperparathyroidism
Acromegaly
Diabetes
Chronic diseases
Rheumatic disorders (juvenile rheumatic arthritis, systemic
lupus erythromatosis and others)
Renal disease
Inflammatory bowel disease
Liver disease
Malabsorption (celiac disease)
Chronic obstructive lung disease
Congenital heart disease
Hemophillia
Leukemia
Lymphoma
Solid tumors
Iatrogenic disorders causing osteopenia/osteoporosis
Glucocorticoid excess-either systemic or inhaled
Anticonvulsants
Chemotherapy
Central Precocious Puberty
Immune suppressant (Cyclosporin)
Radiotherapy
Nutritional Disorders
Malnutrition
Vitamin D deficiency
Vitamin K deficiency
Anorexia Nervosa
Total parenteral nutrition
Preterm infants
Calcium deficiency
Disorders causing disuse osteoporosis
Chronic diseases
Celebral palsy
Huntington disease
Burns
Muscular dystrophy
Others
Idiopathic juvenile osteoporosis
Constitutional delay of pubertyPediatric DXA
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bone. In that case, total body scans may be needed
24). In
the evaluation of localized osteoporosis in osteosarcoma
patients, the hip scan is advised in case of appropriate
pediatric reference data are available. In osteosarcoma pa-
tients, comparisons of both extremities and follow-up stu-
dies of the affected limbs are needed.
There is a significant association between TBLH and
fractures. As a result, the ISCD recommends TBLH mea-
surements instead of total body measurements. However,
many studies show that the total body BMD scan is used
clinically because most pediatric-based software can only
provide total body results. The pediatric normal references
of TBLH are limited.
Analysis of Pediatric DXA Results
In a pediatric DXA report, the Z-score should be as-
sessed instead of the T-score. Subsequently, the patient s ’
anthropometric data, including age, gender, ethnicity,
weight, height, and Tanner stage should be verified. Next,
the patient s position and analyzed ROIs should be verified ’
as appropriate, and it should be confirmed that no artifacts
exist, which would lead to abnormal results. The proper
patient position for DXA scanning is illustrated in Fig 1.
The lumbar spine should be straightened and centered in
the image with visualization of the last rib pair and the
upper sacrum. The femur neck and the femoral shaft
should be parallel to the long axis of the image with only
a small portion of the lesser trochanter visualized. Total
body scanning after proper positioning according to the
machine type provides measurements of total body BMC,
BMD, and body composition including fat, lean body mass,
bone mineral content, and percentage of fat. Extraneous
artifacts, including buttons, coins, enteric tubes, and ortho-
pedic hardware should be excluded from the image. The
next step is to check the Z-score. The Z-score is a
standard deviation score compared to a Korean normal
control adjusted for age and sex. A proper control should
be obtained for interpretation of pediatric DXA results. A
common mistake of erroneous interpretation of pediatric
DXA is to use a T-score based upon a comparison with
peak adult BMD. In one report, 62% of children for referred
for osteoporosis were misdiagnosed because adult re-
ference data was used rather than pediatric norms
25). The
T-score measures the bone density loss occurring from
early adulthood. Its use for analyzing pediatric data will
cause a significant misdiagnosis
6). When T-scores are
obtained, adult software is used to analyze BMD instead of
pediatric software. The analysis algorithm of the adult soft-
ware significantly overestimates the lumbar BMD and un-
derestimates the lumbar BMC relative to the pediatric
software because pediatric bone is naturally less dense
than adult bone
26). The algorithm used in the pediatric DXA
software is adapted for improved edge detection of lower
density pediatric bone in order to address this problem
7,
20). The final step is to verify that the correct version of
the DXA software was used and include this verification in
the DXA reports.
Interpretation of Pediatric DXA
In children and adolescents, the terms low bone mineral “
content or low bone mineral density for chronological age ” “ ”
have been recommended for use in DXA reports rather than
the terms osteopenia and osteoporosis
6). Importantly, the
diagnosis of osteoporosis should not be made solely on the
basis of DXA results . Diagnosis of osteoporosis requires
a clinically significant fracture history such as one long-
bone fracture of the lower extremity, vertebral compression
fracture, and two or more long-bone fractures of the upper
extremities in addition to low bone mass. Low bone mass
is diagnosed when a BMC or areal BMD Z-score of known
ROI is less than or equal to -2.0 (with the Z-score adjus-
ted for age, sex, and body size). If Z scores are not pro-
vided by the DXA software, published pediatric reference
data can be used to calculate them. Several DXA studies
providing normative data from healthy Korean children are
summarized in Table 2. It is essential to use a normal re-
ference obtained from the same instrument because there
are systematic differences among the different DXA ma-
chines.
The pattern of mineral accrual is linked more closely to
pubertal and skeletal maturation than to chronologic age,
and these processes tend to vary with gender and ethnicity
6, 27). For example, children with precocious puberty have
abnormally increased BMD relative to chronological age. On
the other hand, children with constitutional delay exhibit
decreased BMD. For this reason, the influence of height,
bone size, and maturation must be considered during eva-
luation of DXA results. Korean children and adolescents
often have a discrepancy between chronological age and
bone age
10). In particular, many children and adolescentsJS Lim
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with chronic disease have a delayed growth, absent or
arrested puberty, and altered body composition.
The DXA-derived BMD is based upon two dimensional
projection areas of three dimensional structures and pro-
vides an areal BMD rather than volumetric (true) BMD.
This can causes several problems
5, 6), the most significant
of which is that areal bone density may be underestimated
in children with smaller bones and overestimated in larger
children
5, 6). Thus several methods have been proposed to
solve this problem. One of the commonly used methods
makes use of the apparent BMD (BMAD) , a mathematic ““ ” -
ally calculated volumetric BMD. The calculation for BMAD
is: BMAD (g/cm
3)=BMDLS [4/( width)] × π×
28). Another mea-
sure is the adjusted bone mass that is obtained by cor “ ” -
recting the lean body mass or height to minimize the in-
fluence of bone size or lean body mass
29, 30). Another pos-
sible way of making corrections to the BMD is to use bone
age. Height and skeletal maturation generally correlate
with bone age rather than chronological age. Bone age is
more accurate than chronological age in assessing each
individual BMD
6, 10). However, none of the abovementioned
correction methods has been established as the best method
according to the gold standard of successful prediction of
childhood fracture. Nonetheless, it is possible to estimate
how much a reduced BMD can be attributed to smaller bone
size by calculating volumetric BMD or using other correc-
tive methods.
Clinical case studies
The following common examples are pediatrics DXA
studies interpreted at the Korea Cancer Center Hospital.
The reference BMD employed for each ROI is obtained
from ‘Bone Mineral Density according to Age, Bone Age,
Pubertal Stages in Korean Children and Adolescents’
10).
Subject 1 was a 11.1-year-old male without chronic
disease. He was in Tanner stage 1 and weighed 32 kg. His
lumbar BMD, left femur neck BMD, and total body BMD
were 0.671 g/cm
2, 0.762 g/cm
2, and 0.833 g/cm
2 (normal
mean BMD values for a male at the age of 11 are: 0.871±
0.137 g/cm
2, 0.786 0.102 ± g/cm
2, and 0.913 0.070 g/cm ±
2).
According to our normal database, this subject s lumbar, ’
femur neck, and total body BMD were lower than normal,
with Z-scores of 1.5, -0.2, and -1.1 respectively. How − -
ever, his bone age was 9 years. The normal mean lumbar,
femur neck, and total BMD of male bone age of a 9 year old
male is 0.700 0.076 g/cm ±
2, 0.731 0.087g/cm ±
2, and 0.841±
0.051 g/cm
2 respectively. Therefore, the corrected BMD
Z-scores were -0.4, 0.4, and -1.2 respectively. His diag-
nosis was constitutional delay. Thus, he was found to have
a normal BMD according to bone age. On follow-up DXA,
his lumbar BMD, left femur neck BMD, and total body BMD
were 0.701 g/cm
2, 0.782 g/cm
2, and 0.862 g/cm
2 (the nor-
mal mean BMD for a male at the age of 13 are 0.996 0.127 ±
g/cm
2, 0.731 0.087 ± g/cm
2, and 0.841 0.051 g/cm ±
2) res-
pectively and the normal mean BMD values for a male with
a bone age of 11 are 0.789 0.075 g/cm ±
2, 0.813 0.072 g/ ±
cm
2, and 0.896 0.041 g/cm ±
2. The bone age corrected BMD
Z-scores were -1.1, -0.4, and -0.8 respectively. His BMD
increase at each ROI was found to be within normal range.
Subject 2 was a 15.4-year-old female with panhypopi-
tuitarism following an operation for intracranial germinoma.
She presented for a baseline study and was in Tanner stage
1 with a body weight of 40 kg. Her lumbar BMD was 0.740
g/cm
2. Using our normal database, the patient s lumbar BMD ’
Z-score was found to be much less than 4.8. The left −
femur neck BMD was 0.694 g/cm
2 with a Z-score of -1.6.
The total body BMD was 0.805 g/cm
2 with a Z-score of
4.3. The patient was reported as having markedly re − -
duced bone density. However, her bone age was 10 years
(the normal mean BMD at bone age 10 years for a female
is 0.765 0.059 g/cm ±
2). The corrected BMD Z-scores were
-1.1, -0.7, and -2.0 respectively. Her follow-up BMD
Z-scores were same for a period of 3 years after growth
hormone treatment. It should be noted that a patient with
chronic disease exhibits a severe decrease in BMD Z-
Table 2. Normative Data for DXA in Korean Pediatric Subjects.
Year of Publication (Ref.) Authors DXA machine Number Age Site
2009
10)
2007
11)
2009
33)
1998
34)
1995
35)
Lim JS et al.
Lee SHet al.
Oh YJ et al.
Cho HJ et al.
Kim BY et al.
Lunar Prodigy
Hologic QDR Discovery
Hologic QDR Discovery
Norland XR 26
Hologic QDR 2000
514
446
135
75
53
5-20
2-18
6-14
2-15
4-13
Spine, femur, total body, TBLH, BMAD
Spine, femur
Spine, femur
Spine, femur
LumbarPediatric DXA
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score at each ROI with respect to chronologic reference
data. Bone age reference values would better reflect the
patient s actual bone status. Thus, we used the patient s ’ ’
bone age in interpreting the DXA results.
Subject 3 was a 12.3-year-old male with osteosarcoma
in the left femur. On baseline DXA the lumbar BMD was
0.783 g/cm
2 (normal mean BMD at bone age 12 years male;
0.820 0.098 g/cm ±
2). The left femur neck BMD was 0.785
g/cm
2 and right femur neck BMD was 0.773 g/cm
2 (the nor-
mal mean BMD for a male12 years of age is 0.842 0.087 ±
g/cm
2). The Z-score of -0.4, -0.7, and -08 determined
using our database was considered to be within normal
values. During the next 12 months, the patient underwent
a limb salvage operation and chemotherapy with MTX and
lost 7 kg while remaining at Tanner stage 2. On follow-up,
the DXA analysis indicated that the lumbar BMD was 0.971
g/cm
2 (the normal mean lumbar BMD for a male at age 13
years of age is 0.954 0.161 g/cm ±
2). The left femur neck
BMD was 0.480 g/cm
2 and the right femur neck BMD was
0.700 g/cm
2 (the normal mean femur neck BMD for a male
13 years of age is 0.996 0.127 g/cm ±
2). The Z-score of
each ROI was 0.1, -4.1, and -2.3. Thus, the patient had a
slight increase in lumbar BMD value at a time when rapid
bone mineral accrual was expected. However, both femur
neck measurements indicated a decreased BMD, particularly
in the left femur neck. This decrease was rather evident in
the Z-score, ranging from -0.7 to 4.1 in the left femur −
neck. Immobilization might have been the cause of the de-
creased femur neck BMD. After informing the patient of the
DXA results, calcium and vitamin D intake was recom-
mended. Further recommendations for proper exercise
were made to increase BMD, and the patient was counseled
to manage risks of fracture.
Treatment of osteoporosis
Until recently, there has been no consensus on the treat-
ment of osteoporosis in children and adolescents with the
exception of osteogenesis imperfecta. However, the need
for osteoporosis therapy is increasing. The basic approach
for young osteoporotic patients is to first identify and then
eliminate all the known risk factors. Effective control of the
underlying disease, adequate supplementation of calcium
and vitamin D, and advising increased physical activity are
essential and represent the simplest course of action. The
advanced approach involves correcting hormonal deficiency
and using antiresorptive drugs such as bisphosphonates.
The complex issue of treatment with about bisphosphonates
is has been addressed in my previous review
21).
Other indication of pediatric DXA
Bone mineral contents and bone mineral density is an
important part of body composition together with lean body
mass and fat mass. The total (whole) body DXA reports
include not only total body BMD but also lean body mass,
fat mass, percentage of fat and fat distribution (Fig 1). The
body composition difference (especially fat distribution)
between age groups, sex, and ethnicity explain the diffe-
rent risk profiles for metabolic disease
31). The DXA-based
body composition reference data of children and adoles-
cents of diverse ethnicities including Korean have been
published
32).
Conclusion
The gain of optimal PBM during growth is important for
future resistance to osteoporosis and fractures. Because
pediatric DXA is a useful tool for evaluation of the skeletal
health of children and adolescents with chronic disease, the
demand for DXA for children is likely to increase. Pedia-
tricians treating chronic diseases should be aware of pedi-
atric DXA techniques and know when pediatric DXA analy-
sis is recommended, as well as knowing how to interpret
DXA reports.
Pediatricians should remember that 1) DXA analysis is
the preferred method for assessing BMC and areal BMD, 2)
Z-scores (not T-scores) adjusted for with Korean norma-
tive children and adolescent data sets should appear on the
pediatric DXA reports generated using pediatric software,
3) PA spine and TBLH are the preferred sites for mea-
surements of BMC and BMD, 4) a Z-score less than or
equal to -2.0 is indicates low bone mass, and 5) the dia “ ” -
gnosis of osteoporosis in children and adolescents can be
made if low bone mass is observed with clinically signifi-
cant fragile fractures.
When diagnosed with low bone mass, pediatricians should
inform children and their parents of the DXA results. Pe-
diatricians should undertake preventive measures for all
skeletal risk factors by optimizing calcium and vitamin D
intake, addressing deficiencies of sex steroids and recom-
mend as much weight-bearing activity as possible.JS Lim
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